IA-2胞外域自身抗体可细化酮症倾向糖尿病「A+」亚型定义
该研究开发了针对全长IA-2(IA-2FL)及胞外域(IA-2EC)的抗体检测方法,用于分析288例常规胰岛自身抗体阴性的酮症倾向糖尿病(KPD)患者。结论认为检测IA-2FL和IA-2EC抗体可提高KPD患者Aβ分类的准确性。
要点
- 常规检测阴性的KPD患者中可检出IA-2EC抗体(3.5%)及IA-2FL抗体(1.0%)。
- IA-2EC/IA-2FL抗体检测有助于细化KPD的Aβ分类。
- IA-2EC抗体阳性频率与1型及2型糖尿病相似。
核心结论
- 检测IA-2FL和IA-2EC抗体可提高KPD患者Aβ分类的准确性。
研究设计与样本
- 研究开发了靶向IA-2FL和IA-2EC的检测方法,并用于分析288例常规胰岛自身抗体阴性的KPD患者。
主要发现
- IA-2EC和IA-2FL抗体阳性频率与1型及2型糖尿病相似。
临床怎么用
- 对常规胰岛自身抗体阴性的KPD患者,可考虑检测IA-2EC和IA-2FL抗体以细化Aβ分类。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Autoantibodies directed against tyrosine phosphatase IA-2 antibody (IA-2 Ab) are diagnostic for autoimmune type 1 diabetes. Conventional assays target the intracellular domain of IA-2. Among patients with ketosis-prone diabetes (KPD), characterized by presentation with diabetic ketoacidosis (DKA), >60% of adults lack three classic islet autoantibodies-IA-2, GAD65, and ZnT8 Abs-associated with type 1 diabetes. We aimed to determine whether apparently autoantibody-negative ("A-") KPD patients possess occult IA-2 Ab directed against full-length IA-2 (IA-2FL) or its extracellular domain (IA-2EC). RESEARCH DESIGN AND METHODS: We developed an assay that targets IA-2FL and IA-2EC and used it to analyze 288 subjects with A- KPD. RESULTS: Ten A- KPD patients were positive for IA-2EC Ab (3.5%), and three were also positive for IA-2FL Ab (1.0%), similar to frequencies in type 1 and type 2 diabetes. CONCLUSIONS: Measurement of IA-2FL Ab and IA-2EC Ab improves the accuracy of the Aβ classification of KPD patients.
引用
- Mulukutla SN, Acevedo-Calado M, Hampe CS, et al. Autoantibodies to the IA-2 Extracellular Domain Refine the Definition of "A+" Subtypes of Ketosis-Prone Diabetes. Diabetes Care. 2018. PMID: 30327357. doi:10.2337/dc18-0613
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。